Comprehensive Assessment and Classification of High-Grade B-cell Lymphomas

Amir Behdad*, Nathanael G. Bailey

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


High-grade B-cell lymphomas (HGBCLs) are a heterogeneous group of neoplasms that include subsets of diffuse large B-cell lymphoma, Burkitt lymphoma, and lymphomas with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. Morphologically indistinguishable HGBCLs may demonstrate variable clinical courses and responses to therapy. The morphologic evaluation and classification of these neoplasms must be followed by further genetic and immunophenotypic work-up. These additional diagnostic modalities lead to a comprehensive stratification of HGBCL that determines the prognosis and optimal therapy. This article reviews the well-established and emerging biomarkers that are most relevant to the clinical management of HGBCL.

Original languageEnglish (US)
Pages (from-to)41-54
Number of pages14
JournalSurgical Pathology Clinics
Issue number1
StatePublished - Mar 1 2016


  • Burkitt lymphoma
  • Cell of origin
  • Diffuse large B-cell lymphoma
  • MYC

ASJC Scopus subject areas

  • Surgery
  • Pathology and Forensic Medicine


Dive into the research topics of 'Comprehensive Assessment and Classification of High-Grade B-cell Lymphomas'. Together they form a unique fingerprint.

Cite this